Apollomics Inc. SEC filings APLMW
Apollomics Inc. has 183 filings in SEC EDGAR's recent list, going back to Sep 14, 2022. Its latest annual report, Form 20-F, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Aug 12, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Aug 19, 2026 | — |
| EFFECT | Filing | Jun 2, 2026 | — |
| CORRESP | Letter to the SEC | May 28, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2026 | — |
| EFFECT | Filing | May 29, 2024 | — |
| CORRESP | Letter to the SEC | May 28, 2024 | — |
| UPLOAD | Letter from the SEC | May 24, 2024 | — |
| EFFECT | Filing | Apr 24, 2024 | — |
| EFFECT | Filing | Apr 24, 2024 | — |
| CORRESP | Letter to the SEC | Apr 22, 2024 | — |
| CORRESP | Letter to the SEC | Apr 22, 2024 | — |
| CORRESP | Letter to the SEC | Apr 19, 2024 | — |
| CORRESP | Letter to the SEC | Apr 19, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2024 | — |
| CORRESP | Letter to the SEC | Apr 12, 2024 | — |
| CORRESP | Letter to the SEC | Apr 12, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 12, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 12, 2024 | — |
| EFFECT | Filing | Sep 29, 2023 | — |
| EFFECT | Filing | Jul 24, 2023 | — |
| CORRESP | Letter to the SEC | Jul 20, 2023 | — |
| CORRESP | Letter to the SEC | Jul 7, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 23, 2023 | — |
| CERT | Filing | Mar 29, 2023 | — |
| 8-A12B | Filing | Mar 28, 2023 | — |
| SEC STAFF LETTER | Filing | Mar 6, 2023 | — |
| EFFECT | Filing | Feb 28, 2023 | — |
| CORRESP | Letter to the SEC | Feb 24, 2023 | — |
| CORRESP | Letter to the SEC | Feb 21, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 17, 2023 | — |
| 425 | Filing | Feb 10, 2023 | — |
| CORRESP | Letter to the SEC | Dec 22, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2022 | — |
| CORRESP | Letter to the SEC | Dec 14, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 5, 2022 | — |
| SEC STAFF LETTER | Filing | Dec 2, 2022 | — |
| CORRESP | Letter to the SEC | Nov 22, 2022 | — |
| 425 | Filing | Nov 15, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 26, 2022 | — |
| 425 | Filing | Oct 14, 2022 | — |
| 425 | Filing | Oct 7, 2022 | — |
| DRS | Filing | Sep 29, 2022 | — |
| 425 | Filing | Sep 15, 2022 | — |
| 425 | Filing | Sep 14, 2022 | — |
| 425 | Filing | Sep 14, 2022 | — |
| 425 | Filing | Sep 14, 2022 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- APLM (Nasdaq), APLMW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Covina, CA
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1944885
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.